Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval.

Saved in:
Bibliographic Details
Title: Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval.
Authors: Donegan DM; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana., Pivonello R; Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università 'Federico II' di Napoli, Naples, Italy., Stigliano A; Endocrinology, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy., Lardo P; Endocrinology, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy., Kearney T; Department of Endocrinology, Salford Royal Foundation Trust, Salford, Manchester, United Kingdom., Mezősi E; 1st Department of Internal Medicine, Clinical Center, University of Pecs, Pecs, Hungary., Ghigo E; Division of Endocrinology, Diabetology and Metabolism, University of Turin, Turin, Italy., Giordano R; Department of Biological and Clinical Sciences, University of Turin, Turin, Italy., Mariash CN; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana., Feelders RA; Division of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Donaldson K; Jade Consultants (Cambridge) Ltd, Cambridge, United Kingdom., Darpo B; Clario, Philadelphia, Pennsylvania., Xue H; Clario, Philadelphia, Pennsylvania., Custodio JM; Corcept Therapeutics Incorporated, Menlo Park, California., Hand AL; Corcept Therapeutics Incorporated, Menlo Park, California., Moraitis AG; Corcept Therapeutics Incorporated, Menlo Park, California. Electronic address: amoraitis@corcept.com.
Source: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Jan; Vol. 30 (1), pp. 11-18. Date of Electronic Publication: 2023 Oct 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9607439 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1530-891X (Print) Linking ISSN: 1530891X NLM ISO Abbreviation: Endocr Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-891X
DOI:10.1016/j.eprac.2023.09.011